Dr. Kent Yu Feng, MD

Dr. Feng practices at Permanente Medical Group Inc in Santa Clara, California.

Dr. Feng's NPI, 1073976478, was assigned on April 1, 2016. Dr. Feng graduated from UCSF School of Medicine in 2016. Dr. Feng holds California license A160534.

Dr. Feng's primary practice is Permanente Medical Group Inc, at 710 Lawrence Expy, Santa Clara, CA 95051 in Santa Clara County. The practice phone is (408) 851-1000.

Dr. Feng's primary practice is Permanente Medical Group Inc in Santa Clara, California. Dr. Feng is also affiliated with Santa Clara Medical Center. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Feng to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feng practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Feng's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Feng is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Feng's licenses on file in 2 states: California and North Carolina.

CMS data shows 29 Medicare services from Dr. Feng across 1 procedure code in 2024, for 26 Medicare patients. Medicare paid $210 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 26 Medicare patients who saw Dr. Feng in 2024. The largest group is 65 to 74, with 14 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 54% are also on Medicaid. Their average risk score is 3.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Feng's median patient age at 66, with 53% women.

In 2024, Dr. Feng wrote 729 Medicare Part D claims for 148 patients. 83% of them were for generic drugs. CMS names the drug for 661 of them, across 19 drugs with 11 or more claims each, at $93,700 in total drug cost. In 2023, CMS named 420 claims across 13 drugs.

Dr. Feng accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Feng, published from 2014 to 2024. 2021 was the busiest year, with 7. The most frequent topics are Heart Failure, Canagliflozin and Cardiovascular System. Dr. Feng has published most often in Diabetes Obes Metab. Dr. Feng's most frequent co-authors are Kenneth William Mahaffey, MD, Jiho Joseph Han, MD and Kiran Kaur Khush, MD.

Dr. Feng graduated from UCSF School of Medicine in 2016.

Dr. Feng is in network with 3 carriers, including Blue Cross Blue Shield of Michigan, Kaiser Permanente and CMS Medicare. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.